1. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease. Issue 6 (2nd April 2018) Authors: Castro, Grace; Merkel, Patricia A.; Giclas, Hannah E.; Gibula, Andrew; Andersen, Gillian E.; Corash, Laurence M.; Lin, Jin Sying; Green, Jennifer; Knight, Vijaya; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 6(2018) Page Start: 1506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real‐time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA. Issue 2 (7th October 2015) Authors: Bakkour, Sonia; Chafets, Daniel M.; Wen, Li; Dupuis, Kent; Castro, Grace; Green, Jennifer M.; Stassinopoulos, Adonis; Busch, Michael P.; Lee, Tzong‐Hae Journal: Transfusion Issue: Volume 56:Issue 2(2016:Feb.) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model. Issue 6 (11th July 2019) Authors: Slichter, Sherrill J.; Bailey, S. Lawrence; Gettinger, Irena; Pellham, Esther; Christoffel, Todd; Castro, Grace; Green, Jennifer M.; Stassinopoulos, Adonis Journal: Vox sanguinis Issue: Volume 114:Issue 6(2019) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗